NO20003234L - Oralt administrerbare ribavirindoseformer i fast form og fremgangsmÕte for fremstilling av disse - Google Patents

Oralt administrerbare ribavirindoseformer i fast form og fremgangsmÕte for fremstilling av disse

Info

Publication number
NO20003234L
NO20003234L NO20003234A NO20003234A NO20003234L NO 20003234 L NO20003234 L NO 20003234L NO 20003234 A NO20003234 A NO 20003234A NO 20003234 A NO20003234 A NO 20003234A NO 20003234 L NO20003234 L NO 20003234L
Authority
NO
Norway
Prior art keywords
preparing
methods
dosage forms
solid dosage
orally administrable
Prior art date
Application number
NO20003234A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003234D0 (no
Inventor
Stephen M Liebowitz
Elliot I Stupak
Imtiaz A Chaudry
Winston A Vadino
Frank E Bowen
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27130673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20003234(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/997,172 external-priority patent/US5914128A/en
Priority claimed from US08/997,169 external-priority patent/US5916594A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20003234D0 publication Critical patent/NO20003234D0/no
Publication of NO20003234L publication Critical patent/NO20003234L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20003234A 1997-12-22 2000-06-21 Oralt administrerbare ribavirindoseformer i fast form og fremgangsmÕte for fremstilling av disse NO20003234L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/997,172 US5914128A (en) 1997-12-22 1997-12-22 Orally administrable solid dosage form
US08/997,169 US5916594A (en) 1997-12-22 1997-12-22 Process of making solid ribavirin dosage forms
PCT/US1998/026222 WO1999032128A1 (en) 1997-12-22 1998-12-21 Orally administrable solid ribavirin dosage forms and process for making them

Publications (2)

Publication Number Publication Date
NO20003234D0 NO20003234D0 (no) 2000-06-21
NO20003234L true NO20003234L (no) 2000-08-21

Family

ID=27130673

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003234A NO20003234L (no) 1997-12-22 2000-06-21 Oralt administrerbare ribavirindoseformer i fast form og fremgangsmÕte for fremstilling av disse

Country Status (27)

Country Link
US (3) US6337090B1 (hu)
EP (2) EP0991415B1 (hu)
JP (2) JP2001526234A (hu)
KR (1) KR100575389B1 (hu)
CN (1) CN1155388C (hu)
AR (1) AR008977A1 (hu)
AT (1) ATE234103T1 (hu)
AU (1) AU762826B2 (hu)
BR (1) BR9814367A (hu)
CA (4) CA2323849C (hu)
CO (1) CO4970774A1 (hu)
DE (1) DE69812094T2 (hu)
DK (1) DK0991415T3 (hu)
ES (1) ES2191987T3 (hu)
HK (1) HK1034674A1 (hu)
HU (1) HUP0100433A3 (hu)
IL (1) IL136549A (hu)
MY (1) MY119656A (hu)
NO (1) NO20003234L (hu)
NZ (1) NZ504994A (hu)
PE (1) PE20000066A1 (hu)
PL (1) PL190267B1 (hu)
PT (1) PT991415E (hu)
SK (1) SK284520B6 (hu)
TW (1) TW575436B (hu)
WO (1) WO1999032128A1 (hu)
ZA (1) ZA9811726B (hu)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0991415B1 (en) * 1997-12-22 2003-03-12 Schering Corporation Orally administrable solid ribavirin dosage forms and process for making them
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
WO2001066026A2 (en) * 2000-03-06 2001-09-13 Tissuelink Medical, Inc. Fluid delivery system and controller for electrosurgical devices
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
KR20030020137A (ko) * 2001-09-03 2003-03-08 진양제약주식회사 리바비린 건조시럽제
PL368550A1 (en) * 2001-11-02 2005-04-04 Sandoz Ag Process for preparing quick dissolving, high loading ribavirin compositions
DE10227148A1 (de) * 2002-06-18 2004-01-08 Biopartners Gmbh Verwendung von Ribavirin zur Herstellung einer pharmazeutischen Zusammensetzung gegen Bunyaviridae
US7538094B2 (en) * 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
US20040142903A1 (en) * 2003-01-16 2004-07-22 Par Pharmaceutical Inc. Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions
BRPI0408846A (pt) * 2003-03-28 2006-07-04 Pharmasset Inc compostos para o tratamento de infecções por flaviviridae
MX2007002784A (es) * 2004-09-09 2009-02-12 Bayer Animal Health Gmbh Composición farmacéutica en forma de dosificación sólida soluble en agua.
US7723310B2 (en) * 2004-10-18 2010-05-25 Three Rivers Pharmaceuticals, Llc Large dose ribavirin formulations
US8062670B2 (en) * 2005-08-05 2011-11-22 3M Innovative Properties Company Compositions exhibiting improved flowability
CA2666814A1 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
WO2009142852A2 (en) * 2008-05-22 2009-11-26 3M Innovative Properties Company Process for manufacturing flowable powder drug compositions
EP2309978B1 (en) * 2008-06-26 2018-12-26 3M Innovative Properties Company Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
WO2010002613A2 (en) * 2008-07-02 2010-01-07 3M Innovative Properties Company Method of making a dry powder pharmaceutical composition
EP2295037A1 (en) 2009-09-11 2011-03-16 Ratiopharm GmbH Pharmaceutical formulation containing Ribavirin
US10363453B2 (en) 2011-02-07 2019-07-30 New Balance Athletics, Inc. Systems and methods for monitoring athletic and physiological performance
CA2752008A1 (en) 2011-09-13 2013-03-13 Universite De Montreal Combination therapy using ribavirin as elf4e inhibitor
CN106389363A (zh) * 2016-10-18 2017-02-15 广东肇庆星湖生物科技股份有限公司 一种利巴韦林口服固体制剂及其制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3490742A (en) * 1966-01-14 1970-01-20 Staley Mfg Co A E Compressed tablets
US3622677A (en) * 1969-07-07 1971-11-23 Staley Mfg Co A E Compressed tablets containing compacted starch as binder-disintegrant ingredient
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
DE2735600A1 (de) * 1977-08-06 1979-02-15 Dynamit Nobel Ag Verfahren zur herstellung von phthalid
JPS57146593A (en) * 1981-03-09 1982-09-10 Ajinomoto Co Inc Preparation of ribofuranosyltriazole derivative
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4681765A (en) * 1984-09-13 1987-07-21 American Home Products Corporation Rapid releasing triamterene containing gelatin capsule dosage forms for once daily antihypertensive use
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
JPS63216820A (ja) * 1987-03-05 1988-09-09 Chugai Pharmaceut Co Ltd 抗ウイルス剤
GB8800276D0 (en) * 1988-01-07 1988-02-10 Univ Liverpool Medical treatment
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US5192788A (en) * 1988-05-23 1993-03-09 Georgia State University Foundation, Inc. Porphyrin antiviral compositions
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US5122517A (en) * 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
JP2908844B2 (ja) * 1990-06-29 1999-06-21 ヤマサ醤油株式会社 抗ウイルス剤
US5663154A (en) * 1992-01-06 1997-09-02 Glaxo Wellcome Inc. 2',3'-dideoxy-3'-fluoro-purine ribonucleosides
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
US5358721A (en) * 1992-12-04 1994-10-25 Alza Corporation Antiviral therapy
JPH06298665A (ja) * 1993-04-14 1994-10-25 Toray Ind Inc 抗ウイルス剤
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
US5492692A (en) * 1993-08-17 1996-02-20 University Of Kentucky Research Foundation Coated products with potent anti-HIV and antimicrobial properties
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CA2135669A1 (en) 1994-11-10 1996-05-11 Nils O. Johannesson Ribavirin as hepato (liver) protecting agent
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US6106865A (en) * 1995-01-09 2000-08-22 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
NZ302926A (en) * 1995-02-28 1998-10-28 Hoechst Marion Roussel Inc Composition for use as antihistamines comprising piperidinoalkanol derivatives and inert ingredients
US6387365B1 (en) * 1995-05-19 2002-05-14 Schering Corporation Combination therapy for chronic hepatitis C infection
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US5723589A (en) * 1995-12-21 1998-03-03 Icn Pharmaceuticals Carbohydrate conjugated bio-active compounds
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
US6172046B1 (en) * 1997-09-21 2001-01-09 Schering Corporation Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
US5914128A (en) * 1997-12-22 1999-06-22 Schering Corporation Orally administrable solid dosage form
EP0991415B1 (en) * 1997-12-22 2003-03-12 Schering Corporation Orally administrable solid ribavirin dosage forms and process for making them
US5916594A (en) * 1997-12-22 1999-06-29 Schering Corporation Process of making solid ribavirin dosage forms

Also Published As

Publication number Publication date
HUP0100433A3 (en) 2003-01-28
US6051252A (en) 2000-04-18
MY119656A (en) 2005-06-30
PL341230A1 (en) 2001-03-26
IL136549A0 (en) 2001-06-14
ATE234103T1 (de) 2003-03-15
JP2001526234A (ja) 2001-12-18
ES2191987T3 (es) 2003-09-16
DE69812094D1 (de) 2003-04-17
AU762826B2 (en) 2003-07-03
CA2323849A1 (en) 1999-07-01
AR008977A1 (es) 2000-03-08
CA2300452A1 (en) 1999-07-01
KR100575389B1 (ko) 2006-05-03
BR9814367A (pt) 2000-10-17
US6335032B1 (en) 2002-01-01
CA2300452C (en) 2000-11-28
IL136549A (en) 2005-05-17
WO1999032128A1 (en) 1999-07-01
KR20010033441A (ko) 2001-04-25
CN1155388C (zh) 2004-06-30
PT991415E (pt) 2003-06-30
JP2006083189A (ja) 2006-03-30
HUP0100433A2 (hu) 2001-12-28
EP0991415A1 (en) 2000-04-12
TW575436B (en) 2004-02-11
EP1321147A1 (en) 2003-06-25
CA2323849C (en) 2002-06-11
DK0991415T3 (da) 2003-06-16
HK1034674A1 (en) 2001-11-02
CO4970774A1 (es) 2000-11-07
CA2365412C (en) 2002-09-17
CA2287056C (en) 2000-08-15
SK284520B6 (sk) 2005-05-05
AU2199199A (en) 1999-07-12
CA2287056A1 (en) 1999-07-01
PL190267B1 (pl) 2005-11-30
US6337090B1 (en) 2002-01-08
PE20000066A1 (es) 2000-02-09
EP0991415B1 (en) 2003-03-12
NO20003234D0 (no) 2000-06-21
NZ504994A (en) 2002-10-25
SK8942000A3 (en) 2001-04-09
ZA9811726B (en) 1999-06-21
CA2365412A1 (en) 1999-07-01
DE69812094T2 (de) 2003-12-24
CN1283117A (zh) 2001-02-07

Similar Documents

Publication Publication Date Title
NO20003234L (no) Oralt administrerbare ribavirindoseformer i fast form og fremgangsmÕte for fremstilling av disse
FI973749A (fi) Suun kautta annosteltava 2-metyylitienobentsodiatsepiinivalmiste
NO996352L (no) Kappaagonistforbindelser, farmasøytiske formuleringer og metode for forhindring og behandling av kløe med disse
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
NO990944D0 (no) Tablett med kontrollert frigivelse av alfuzosinhydroklorid
DE69808432T2 (de) Transfereinrichtung
DK1112174T3 (da) Isosorbidholdige polyestere og fremgangsmåder til fremstiling heraf
IS5869A (is) Hraðlosandi tafla
NO984290D0 (no) Farmas°ytisk nyttige forbindelser
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
DE59802126D1 (de) Tablettentestgerät
DE69535637D1 (de) Übertragungs-LSI
DE29519724U1 (de) Transportierbares tragbares Laufstall-System
NO993506L (no) Rörfundament og fremgangsmÕte for tilvirkning av dette
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO20014393L (no) 1,3,4-oksadiazol-derivater og fremgangsmåte for fremstilling av disse
DE29801440U1 (de) Tabletten-Einnahmehilfe
DE69723824D1 (de) Verteilergetriebe
NO20010575L (no) Nye antikonvulsiv virkende 4-amino-1-aryl-pyridin-2-oner og fremgangsmÕter for fremstilling av disse
LV11433A (lv) Ziede brucu un nobrazumu arstesanai
KR950031480U (ko) 웨이퍼 이동구
NO20021143D0 (no) Antikonvulsiv og anxiolytisk virkende 4-amino-1-aryl-1,5- dihydro-pyrrol-2-oner og fremgangsmåte for fremstilling av disse
KR970021181U (ko) 일체형 렌치
DE29512130U1 (de) Kessel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application